8-K: Chicago Atlantic BDC Reports Strong Q2 2025 Results

Chicago Atlantic BDC, Inc. announced robust second quarter 2025 financial results, driven by increased investment income and portfolio growth, alongside a declared dividend.

Summary

• Total gross investment income for the second quarter ended June 30, 2025, was $13.1 million, an increase from $11.9 million in the prior quarter.
• Net investment income for the quarter was $7.7 million, or $0.34 per weighted average share outstanding, consistent with the previous quarter.
• The total investment portfolio reached $307.5 million at fair value as of June 30, 2025, across 31 portfolio companies.
• Net asset value (NAV) per share increased slightly to $13.23 on June 30, 2025, from $13.19 as of March 31, 2025.
• A dividend of $0.34 per share was declared for the quarter ending September 30, 2025, payable on October 10, 2025, to shareholders of record on September 29, 2025.
• The company funded $39.1 million in aggregate par value across nine portfolio companies during the second quarter of 2025.
• Subsequent to quarter end, an additional $17.2 million in investments were funded across five borrowers.
• As of June 30, 2025, there were no loans on non-accrual status.
• Liquidity stood at $108.8 million as of June 30, 2025, including $13.8 million of cash and cash equivalents and $5.0 million of borrowings outstanding on its senior credit facility.
• As of August 14, 2025, the company had no outstanding borrowings on its senior credit facility and $125.4 million of liquidity.
• Total net assets as of June 30, 2025, were $301.8 million, up from $301.0 million as of March 31, 2025.

Sentiment

Score: 8

Explanation: The filing indicates strong financial performance with increased investment income, stable net investment income per share, and a growing NAV. The company's strategic focus on underserved markets, particularly cannabis, continues to yield high returns and maintain strong credit quality with zero non-accruals. Significant liquidity and a robust pipeline suggest continued growth potential. While expenses increased, the overall financial health and strategic positioning are positive.

Positives

• Total gross investment income increased to $13.1 million in Q2 2025 from $11.9 million in Q1 2025, indicating strong revenue growth.
• Net investment income remained stable at $0.34 per weighted average share, demonstrating consistent profitability.
• Net asset value (NAV) per share saw a slight increase to $13.23 from $13.19, reflecting growth in net assets.
• Successfully deployed $39.1 million in new investments during Q2 2025 and an additional $17.2 million subsequent to quarter end, showcasing active portfolio growth.
• Maintained a healthy investment portfolio of $307.5 million at fair value across 31 companies.
• Reported zero loans on non-accrual status as of June 30, 2025, indicating excellent credit quality and risk management.
• Achieved significant liquidity of $125.4 million as of August 14, 2025, with no outstanding borrowings on the senior credit facility, providing ample capital for future investments.
• Generated a high gross weighted-average yield of 16.1% on debt investments, significantly outperforming industry benchmarks.
• 100% of current company debt investments are senior secured, enhancing capital preservation and downside protection.
• 76% of the portfolio consists of floating rate loans, with 46% at their respective floor, offering protection against rising interest rates.
• The originations pipeline of cannabis and non-cannabis opportunities is growing to over $780 million across the Chicago Atlantic platform, signaling strong future growth potential.

Negatives

• Net expenses increased to $5.4 million in Q2 2025 from $4.3 million in Q1 2025.
• Interest expense increased to $301,260 in Q2 2025 from $145,381 in Q1 2025, likely due to increased utilization of the credit facility.
• General and administrative expense increased to $1,366,783 in Q2 2025 from $974,477 in Q1 2025.

Risks

• Forward-looking statements involve substantial risks and uncertainties, and undue reliance should not be placed on them.
• Actual results could differ materially from forecasts due to known and unknown risks, uncertainties, and other factors.
• Investment in securities of this type presents inherent risks, and the value of investments can fluctuate, potentially leading to a loss of principal.
• The cannabis industry, a primary focus, carries regulatory, reputational, and other specific risks.
• Each state in the cannabis industry has unique investment characteristics, supply and demand dynamics, and legal frameworks, requiring sophisticated understanding and expertise.

Future Outlook

The Company's CEO, Peter Sack, highlighted a growing originations pipeline of over $780 million across the Chicago Atlantic platform, encompassing both cannabis and non-cannabis opportunities. The new senior credit facility is expected to provide a distinct advantage in meeting borrower needs for upcoming debt maturities, growth capital, and potential ESOP transactions. The company aims to continue its focus on underserved market niches and maintain its strong credit metrics.

Management Comments

• "Through a consistent and measured approach, we deployed $56 million in gross fundings by principal value during the second quarter and to date in the third quarter."
• "These investments were partially funded with borrowings on our new senior credit facility."
• "With the originations pipeline of cannabis and non-cannabis opportunities growing to over $780 million across the Chicago Atlantic platform, we believe the credit facility will provide a distinct advantage in meeting the needs for borrowers upcoming debt maturities, growth capital and potential ESOP transactions."

Industry Context

Chicago Atlantic BDC operates as a specialty finance company primarily focused on direct loans to privately held middle-market companies, with a significant emphasis on the cannabis industry. This niche focus allows the company to capitalize on opportunities in highly complex and regulated industries that are underserved by traditional capital providers, leading to higher interest rates and stronger structural protections. The U.S. cannabis industry is experiencing significant growth, with estimated retail revenue of $35 billion in 2025, projected to reach $69 billion by 2031, creating a substantial addressable debt market. The company's strategy of investing in these dislocated sectors aims to generate uncorrelated, idiosyncratic credit alpha.

Comparison to Industry Standards

• Chicago Atlantic BDC (LIEN) generated a 16.1% weighted average portfolio yield on debt investments as of June 30, 2025.
• This yield significantly outperforms the US High Yield Index (7.3%), the US Leveraged Loan Yield Index (8.8%), and the average portfolio yield of public BDCs (11.8% as per Ladenburg Thalmann as of June 3, 2025).
• The company's focus on underserved sectors, particularly cannabis, allows for pricing power and structural protections not typically found in traditional leveraged finance markets.
• All debt investments are senior secured, providing enhanced downside protection compared to some broader market debt instruments.
• The company reported a 0% non-accrual rate, indicating strong credit quality, which is a favorable comparison to general industry standards for credit portfolios.

Stakeholder Impact

• Shareholders: Positive impact due to stable net investment income per share, increased NAV per share, and a declared dividend of $0.34 per share. The company's strong performance and strategic growth initiatives could lead to increased shareholder value.
• Borrowers: The new senior credit facility and growing pipeline indicate increased capacity to meet the debt financing needs of middle-market companies, particularly in the cannabis sector, for growth capital, debt maturities, and ESOP transactions.

Next Steps

• Host a conference call and live audio webcast on August 14, 2025, at 9:00 a.m. Eastern Time to discuss Q2 2025 financial results.
• Continue to monitor the Investor Relations page of the company's website for important information, press releases, SEC filings, and earnings updates.
• Utilize the new senior credit facility to meet borrower needs for upcoming debt maturities, growth capital, and potential ESOP transactions.
• Deploy capital from the growing originations pipeline of over $780 million.

Key Dates

Recommendation

The company demonstrates robust financial health with increasing investment income, a stable net investment income per share, and a growing NAV. Its unique focus on the underserved cannabis and lower middle-market sectors provides a significant competitive advantage, evidenced by a 16.1% weighted-average portfolio yield that substantially outperforms industry benchmarks. The zero non-accrual rate highlights excellent credit quality. With ample liquidity and a substantial $780 million originations pipeline, the company is well-positioned for continued growth and strong risk-adjusted returns. The consistent dividend declaration further enhances its attractiveness to income-focused investors. The combination of strong performance, strategic positioning, and growth prospects makes it a compelling investment.

Keywords

Chicago Atlantic BDC, LIEN, BDC, Business Development Company, Specialty Finance, Cannabis Lending, Direct Lending, Senior Secured Loans, Private Credit, Financial Results, Investment Portfolio, Net Asset Value, Dividend, Liquidity, Middle Market Lending, Underserved Sectors, Q2 2025 Earnings